எரிஸ் ஆயுள் அறிவியல் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எரிஸ் ஆயுள் அறிவியல் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எரிஸ் ஆயுள் அறிவியல் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

Eris Lifesciences plans ₹130 crore manufacturing facility in Gujarat

Eris Lifesciences plans ₹130 crore manufacturing facility in Gujarat
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Amit Bakshi , Eris Lifesciences , Eris Lifesciences Limited , Executive Director , Chief Operating Officer , அமித் பக்ஷி , எரிஸ் ஆயுள் அறிவியல் , எரிஸ் ஆயுள் அறிவியல் வரையறுக்கப்பட்டவை , நிர்வாகி இயக்குனர் , தலைமை இயங்குகிறது அதிகாரி ,

Eris Lifesciences Limited reappoints MD and Whole-Time Director

Eris Lifesciences Limited reappoints MD and Whole-Time Director
Posted On:
2021-04-01 03:01:53
(Time Zone: Arizona, USA)
Based on the recommendation of the Nomination and Remuneration Committee and their own consideration, the Board of Directors of Eris Lifesciences Limited at their meeting held on 31st March 2021 has approved the re-appointment of Mr. Amit Bakshi (DIN: 01250925) as a Managing Director of the Company for a further period of five (5) years with effect from April 1st 2021, subject to the approval of the shareholders, in the usual course.
The board also approved the re-appointment of Mr. Inderjeet Singh Negi (DIN: 01255388) as a Whole-Time Director of the Company for a further period of five (5) years with effect from April 1st 2021, subject to the approval of the shareholders, in the usual course. ....

United States , Amit Indubhushan Bakshi , Amit Bakshi , Hemwati Nandan Bahuguna Garhwal University Srinagar , Eris Lifesciences , Board Of Directors Eris Lifesciences , Eris Lifesciences Ltd , Remuneration Committee , Intas Pharmaceuticals , Ernst Young , Life Sciences Limited , Time Zone , Eris Lifesciences Limited , Managing Director , Inderjeet Singh Negi , Whole Time Director , Hemwati Nandan Bahuguna Garhwal University , Intas Pharmaceuticals Limited , ஒன்றுபட்டது மாநிலங்களில் , அமித் பக்ஷி , ஹேம்வதி நந்தன் பஹுகுண கர்வாள் பல்கலைக்கழகம் ஸ்ரீநகர் , எரிஸ் ஆயுள் அறிவியல் , பலகை ஆஃப் இயக்குநர்கள் எரிஸ் ஆயுள் அறிவியல் , எரிஸ் ஆயுள் அறிவியல் லிமிடெட் , இன்டாஸ் மருந்துகள் , எர்னிஸ்ட இளம் ,

Branded Generics Market is Projected to Grow Massively in Near Future – KSU

The
Branded Generics Market research report thoroughly explains each and every aspect related to the Global Branded Generics Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
Branded Generics Market Insight:
Global Branded Generics Market is expected to rise from its initial estimated value of USD 232.83 billion in 2018 to a projected value of USD 421.15 billion by 2026, registering a CAGR of 7.69% in the forecast period of 2019-2026. This rise in market value can be attributed to growing need for cheaper treatment options and pharmaceutical drugs required by patients. ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , Zydus Cadila , Asia Pacific , Stada Arzneimittel , Sun Pharmaceutical Industries Ltd , Teva Pharmaceutical Industries Ltd , Pfizer Inc , Aspen Holdings , Bausch Health , Apotex Inc , Lupin Pharmaceuticals Inc , Cipla Inc , Eris Lifesciences , Research Methodology , Market Research , Contents Of This Premium Research , Reddy Laboratories Ltd , Branded Generics Market , Global Branded Generics Market , Generics Market Insight , Including Full , Key Players ,

Eris Lifesciences Limited appoints Mr. Rajeev Dalal as an Additional Independent Director

Eris Lifesciences Limited appoints Mr. Rajeev Dalal as an Additional Independent Director
Posted On:
2020-12-20 05:32:12
(Time Zone: Arizona, USA)
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Eris Lifesciences Limited have passed a circular resolution on December 19, 2020, approving appointment of Mr. Rajeev Dalal (DIN : 00222650) as an Additional Director (Non‐Executive Independent Director) on the Board of Directors of the Company with effect from December 19, 2020 for a term of 5 (five) years upto December 18, 2025, subject to approval of the Shareholders of the Company.
Profile Summary of Mr. Rajeev Dalal: Mr. Rajeev Dalal is a Member of the Institute of Company Secretaries of India. Further he also holds degree of Bachelor of Law and Bachelor of Commerce. He has also been a member of the Committee appointed by the Securities Exchange Board of India (SEBI) for improving disclosure standards in ....

Rajeev Dalal , Eris Lifesciences , Ind Global Finance Trust , Financial Services , Board Of Directors Eris Lifesciences , Eris Lifesciences Ltd , Shareholders Of The Company , Remuneration Committee , Ernst Young , Securities Exchange Board Of India , Board Of Directors The Company , Life Sciences Limited , Additional Independent , Eris Lifesciences Limited , Executive Independent Director , Company Secretaries , Securities Exchange Board , Corporate Finance , Private Equity , ராஜீவ் தலால் , எரிஸ் ஆயுள் அறிவியல் , இந்த் உலகளாவிய நிதி நம்பிக்கை , நிதி சேவைகள் , பலகை ஆஃப் இயக்குநர்கள் எரிஸ் ஆயுள் அறிவியல் , எரிஸ் ஆயுள் அறிவியல் லிமிடெட் , பங்குதாரர்கள் ஆஃப் தி நிறுவனம் ,